Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Ambys
Sort By
Newest First
1 / 1
1 / 1
Drug Designation
Alector Receives Orphan Drug Designation from the U.S. FDA for AL001 for the Treatment of Frontotemporal Dementia
Alector
PR-M08-18-NI-080
Aug 21, 2018
Partnership
Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class Therapies for the Treatment of Serious Liver Diseases
Cytotheryx
PR-M08-18-NI-081
Aug 21, 2018
Regenerative Medicine Therapies
Ambys Medicines Launches with $140 Million to Pioneer Regenerative Medicine Therapies for Serious Liver Diseases
Cytotheryx
PR-M08-18-NI-079
Aug 20, 2018
